{"id":"W2977396843","doi":"10.1097/pai.0000000000000800","title":"Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)","year":2019,"lang":"en","type":"article","venue":"Applied immunohistochemistry & molecular morphology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; Calgary Laboratory Services; St. Michael's Hospital; Jewish General Hospital; University of Manitoba; Juravinski Cancer Centre; University of British Columbia; University of Calgary; McGill University Health Centre; McGill University; BC Cancer Agency; University of Alberta; Université Laval; Dalhousie University; Royal University Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Oncology; Cancer; Internal medicine; Lung cancer; Biomarker; Clinical trial; Disease; Guideline; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002710486,0.000316947,0.0007711426,0.00009517757,0.0002633161,0.00002730528,0.0002565701,0.0008839902,0.00003289834],"category_scores_gemma":[0.006055031,0.0002882663,0.0002881744,0.0004264211,0.0002437288,0.00004157677,0.00004515627,0.000295577,0.00000198322],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004431714,"about_ca_system_score_gemma":0.001389293,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0488529,"about_ca_topic_score_gemma":0.01398095,"domain_scores_codex":[0.9970279,0.0001458008,0.001272268,0.0006008495,0.000179941,0.0007732422],"domain_scores_gemma":[0.9950356,0.001604792,0.001118529,0.0004207263,0.00171865,0.0001017329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002372874,0.0001171673,0.06215334,0.00008598778,0.0003209138,0.00000675382,0.0003344411,0.0000154956,0.9217362,0.00003123868,0.003088919,0.009736708],"study_design_scores_gemma":[0.0313773,0.005689804,0.3970548,0.0004775015,0.001550041,0.0001269844,0.004042822,0.0007275579,0.494504,0.002544756,0.060097,0.001807478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918357,0.002128565,0.000390222,0.001485846,0.0005968931,0.002617596,0.0006822823,0.00003962959,0.0002233026],"genre_scores_gemma":[0.9818649,0.00009209337,0.01346735,0.00192499,0.0001130461,0.001415108,0.0008717232,0.0000566594,0.0001941109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4272322,"threshold_uncertainty_score":0.999957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05631065346560763,"score_gpt":0.3551011734057867,"score_spread":0.2987905199401791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}